Leaders:

Large scale evidence and replication: insights from rheumatology and beyond

J P A Ioannidis

Ann Rheum Dis 2005; 64: 345-346.
Published Online First: 30 September 2004. doi:10.1136/ard.2004.027979

[Extract] [Full Text] [PDF] [Request Permissions]

Reviews:

Primary Sjögren’s syndrome: new clinical and therapeutic concepts

M Ramos-Casals, A G Tzioufas, and J Font

Ann Rheum Dis 2005; 64: 347-354.
Published Online First: 21 October 2004. doi:10.1136/ard.2004.025676

[Abstract] [Full Text] [PDF] [Request Permissions]

Lesson of the month:

Cervical complications of rheumatoid arthritis

M J Kauppi, A Barcelos, and J A P da Silva

Ann Rheum Dis 2005; 64: 355-358. doi:10.1136/ard.2003.020230

[Extract] [Full Text] [PDF] [Request Permissions]

Extended reports:

Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors

T R D J Radstake, R van der Voort, M ten Brummelhuis, M de Waal Malefijt, M Looman, C G Figdor, W B van den Berg, P Barrera, and G J Adema

Ann Rheum Dis 2005; 64: 359-367.
Published Online First: 26 August 2004. doi:10.1136/ard.2003.017566

[Abstract] [Full Text] [PDF] [Request Permissions]

Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis

P L E M van Lent, P N Span, A W Sloetjes, T R D J Radstake, A W T van Lieshout, J J T M Heuvel, C G J Sweep, and W B van den Berg

Ann Rheum Dis 2005; 64: 368-374.
Published Online First: 14 October 2004. doi:10.1136/ard.2004.027870

[Abstract] [Full Text] [PDF] [Request Permissions]

Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography

E Naredo, G Bonilla, F Gamero, J Uson, L Carmona, and A Laffon

Ann Rheum Dis 2005; 64: 375-381. doi:10.1136/ard.2004.023929

[Abstract] [Full Text] [PDF] [Request Permissions]

Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement

A Del Rosso, O Distler, A F Milia, C Emanueli, L Ibba-Manneschi, S Guiducci, M L Conforti, S Generini, A Pignone, S Gay, P Madeddu, and M Matucci-Cerinic

Ann Rheum Dis 2005; 64: 382-387. doi:10.1136/ard.2004.023382

[Abstract] [Full Text] [PDF] [Request Permissions]

Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes

E Maneiro, M J López-Armada, M C de Andres, B Caramés, M A Martín, A Bonilla, P del Hoyo, F Galdo, J Arenas, and F J Blanco

Ann Rheum Dis 2005; 64: 388-395. doi:10.1136/ard.2004.022152

[Abstract] [Full Text] [PDF] [Request Permissions]

Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis

A Boonen, R van den Heuvel, A van Tubergen, M Goossens, J L Severens, D van der Heijde, and S van der Linden

Ann Rheum Dis 2005; 64: 396-402.
Published Online First: 22 July 2004. doi:10.1136/ard.2003.019711

[Abstract] [Full Text] [PDF] [Request Permissions]

Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF

C Eriksson, S Engstrand, K-G Sundqvist, and S Rantapää-Dahlqvist

Ann Rheum Dis 2005; 64: 403-407.
Published Online First: 5 August 2004. doi:10.1136/ard.2004.024182

[Abstract] [Full Text] [PDF] [Request Permissions]

Inhibition of TNF during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF blockade in rheumatoid arthritis

A W T van Lieshout, P Barrera, R L Smeets, G J Pesman, P L C M van Riel, W B van den Berg, and T R D J Radstake

Ann Rheum Dis 2005; 64: 408-414.
Published Online First: 15 July 2004. doi:10.1136/ard.2004.023259

[Abstract] [Full Text] [PDF] [Request Permissions]

Effect of treatment of rheumatoid arthritis with infliximab on IFN, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity

M Kawashima and P Miossec

Ann Rheum Dis 2005; 64: 415-418.
Published Online First: 29 July 2004. doi:10.1136/ard.2004.022731

[Abstract] [Full Text] [PDF] [Request Permissions]

Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein

M Neidhart, F Zaucke, R von Knoch, A Jüngel, B A Michel, R E Gay, and S Gay

Ann Rheum Dis 2005; 64: 419-424.
Published Online First: 2 September 2004. doi:10.1136/ard.2004.023135

[Abstract] [Full Text] [PDF] [Request Permissions]

Lower limb arterial incompressibility and obstruction in rheumatoid arthritis

I del Rincón, R W Haas, S Pogosian, and A Escalante

Ann Rheum Dis 2005; 64: 425-432.
Published Online First: 22 July 2004. doi:10.1136/ard.2003.018671

[Abstract] [Full Text] [PDF] [Request Permissions]

Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity

A M M Eijsbouts, F H J van den Hoogen, R F J M Laan, C G J Sweep, A R M M Hermus, and L B A van de Putte

Ann Rheum Dis 2005; 64: 433-437.
Published Online First: 19 August 2004. doi:10.1136/ard.2002.001347

[Abstract] [Full Text] [PDF] [Request Permissions]

Evidence for familial aggregation of hand, hip, and spine but not knee osteoarthritis in siblings with multiple joint involvement: the GARP study

N Riyazi, I Meulenbelt, H M Kroon, K H Ronday, M-P Hellio le Graverand, F R Rosendaal, F C Breedveld, P E Slagboom, and M Kloppenburg

Ann Rheum Dis 2005; 64: 438-443.
Published Online First: 30 September 2004. doi:10.1136/ard.2004.024661

[Abstract] [Full Text] [PDF] [Request Permissions]

Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus

N Marto, M L Bertolaccini, E Calabuig, G R V Hughes, and M A Khamashta

Ann Rheum Dis 2005; 64: 444-448.
Published Online First: 29 July 2004. doi:10.1136/ard.2004.024943

[Abstract] [Full Text] [PDF] [Request Permissions]

A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis

L S Lohmander, D McKeith, O Svensson, M Malmenäs, L Bolin, A Kalla, G Genti, J Szechinski, C Ramos-Remus for the STAR Multinational Study Group

Ann Rheum Dis 2005; 64: 449-456.
Published Online First: 2 September 2004. doi:10.1136/ard.2004.023572

[Abstract] [Full Text] [PDF] [Request Permissions]

Distinct tumour necrosis factor , interferon , interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener’s granulomatosis

B M Spriewald, O Witzke, R Wassmuth, R R Wenzel, M-L Arnold, T Philipp, and J R Kalden

Ann Rheum Dis 2005; 64: 457-461. doi:10.1136/ard.2004.025809

[Abstract] [Full Text] [PDF] [Request Permissions]

Pathogenic role of anti-ß2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of ß2-glycoprotein I binding to trophoblast cells and functional effects of anti-ß2-glycoprotein I antibodies in vitro

N Di Simone, E Raschi, C Testoni, R Castellani, M D’Asta, T Shi, S A Krilis, A Caruso, and P L Meroni

Ann Rheum Dis 2005; 64: 462-467.
Published Online First: 15 July 2004. doi:10.1136/ard.2004.021444

[Abstract] [Full Text] [PDF] [Request Permissions]

Concise reports:

Analysis of the insertion/deletion related polymorphism within T cell antigen receptor ß variable genes in primary Sjögren’s syndrome

C A Lawson, I J Donaldson, S J Bowman, J Shefta, A W Morgan, A Gough, J D Isaacs, B Griffiths, P Emery, C T Pease, and A W Boylston

Ann Rheum Dis 2005; 64: 468-470. doi:10.1136/ard.2003.012823

[Abstract] [Full Text] [PDF] [Request Permissions]

B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjögren’s syndrome

N M Van Mello, S R Pillemer, P P Tak, and V Sankar

Ann Rheum Dis 2005; 64: 471-473. doi:10.1136/ard.2004.022707

[Abstract] [Full Text] [PDF] [Request Permissions]

Genetic association analysis of the IGFBP7, ADAMTS3, and IL8 genes as the potential osteoarthritis susceptibility that maps to chromosome 4q

C Kawahara, T Forster, K Chapman, A Carr, and J Loughlin

Ann Rheum Dis 2005; 64: 474-476. doi:10.1136/ard.2004.027342

[Abstract] [Full Text] [PDF] [Request Permissions]

DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage

E Pöschl, A Fidler, B Schmidt, A Kallipolitou, E Schmid, and T Aigner

Ann Rheum Dis 2005; 64: 477-480. doi:10.1136/ard.2004.022509

[Abstract] [Full Text] [PDF] [Request Permissions]

Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers

Y Allanore, D Borderie, C Meune, H Lemaréchal, S Weber, O G Ekindjian, and A Kahan

Ann Rheum Dis 2005; 64: 481-483. doi:10.1136/ard.2003.020040

[Abstract] [Full Text] [PDF] [Request Permissions]

ß Thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis

O Kowal-Bielecka, K Kowal, A Lewszuk, A Bodzenta-Lukaszyk, J Walecki, and S Sierakowski

Ann Rheum Dis 2005; 64: 484-486. doi:10.1136/ard.2004.022970

[Abstract] [Full Text] [PDF] [Request Permissions]

Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis

V Pokorny, F McQueen, S Yeoman, M Merriman, A Merriman, A Harrison, J Highton, and L McLean

Ann Rheum Dis 2005; 64: 487-490.
Published Online First: 26 August 2004. doi:10.1136/ard.2004.023333

[Abstract] [Full Text] [PDF] [Request Permissions]

Radiographic progression in children with polyarticular juvenile rheumatoid arthritis: a pilot study

T Mason, A M Reed, A M Nelson, and K B Thomas

Ann Rheum Dis 2005; 64: 491-493. doi:10.1136/ard.2003.017053

[Abstract] [Full Text] [PDF] [Request Permissions]

CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis

E Larsson, H E Harris, K Palmblad, B Månsson, T Saxne, and L Klareskog

Ann Rheum Dis 2005; 64: 494-496. doi:10.1136/ard.2004.021550

[Abstract] [Full Text] [PDF] [Request Permissions]

Tumour necrosis factor blockade in treatment resistant pigmented villonodular synovitis

E-J A Kroot, M C Kraan, T J M Smeets, M Maas, P P Tak, and J M G W Wouters

Ann Rheum Dis 2005; 64: 497-499.
Published Online First: 5 August 2004. doi:10.1136/ard.2004.025692

[Abstract] [Full Text] [PDF] [Request Permissions]

Letters:

Recurrent limp in a young boy

F Falcini, T Giani, A Lippi, M Resti, and G Simonini

Ann Rheum Dis 2005; 64: 500. doi:10.1136/ard.2004.026971

[Extract] [Full Text] [PDF] [Request Permissions]

Finger joint swellings in a teenager: juvenile rheumatoid arthritis or a psychiatric disorder?

B Ostendorf, C Iking-Konert, M Cohnen, and M Schneider

Ann Rheum Dis 2005; 64: 501-502. doi:10.1136/ard.2004.023234

[Extract] [Full Text] [PDF] [Request Permissions]

Worse patient VAS occurs at weeks 7 and 8 after infliximab infusions

N Shenker, R Haigh, and A Clarke

Ann Rheum Dis 2005; 64: 502-503. doi:10.1136/ard.2004.021725

[Extract] [Full Text] [PDF] [Request Permissions]

Glucocorticoid receptor polymorphisms in Korean patients with rheumatoid arthritis

E B Lee, J Y Kim, Y J Lee, and Y W Song

Ann Rheum Dis 2005; 64: 503-504. doi:10.1136/ard.2004.023432

[Extract] [Full Text] [PDF] [Request Permissions]

Tenascin-X: a candidate gene for benign joint hypermobility syndrome and hypermobility type Ehlers-Danlos syndrome?

M C Zweers, M Kucharekova, and J Schalkwijk

Ann Rheum Dis 2005; 64: 504-505. doi:10.1136/ard.2004.026559

[Extract] [Full Text] [PDF] [Request Permissions]

Multiple venous thrombosis in SAPHO syndrome

T Kawabata, Y Morita, A Nakatsuka, H Kagawa, M Kawashima, T Sei, M Yamamura, and H Makino

Ann Rheum Dis 2005; 64: 505-506. doi:10.1136/ard.2004.027722

[Extract] [Full Text] [PDF] [Request Permissions]

A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis

P V Gardiner, A L Bell, A J Taggart, G Wright, F Kee, A Smyth, R McKane, J Lee, M E Rooney, and E Whitehead

Ann Rheum Dis 2005; 64: 506-507. doi:10.1136/ard.2004.025015

[Extract] [Full Text] [PDF] [Request Permissions]

No improvement in a pilot study of tai chi exercise in rheumatoid arthritis

T Uhlig, C Larsson, A-G Hjorth, S Ødegård, and T K Kvien

Ann Rheum Dis 2005; 64: 507-509. doi:10.1136/ard.2004.022483

[Extract] [Full Text] [PDF] [Request Permissions]

Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab

F Broussais, M Kawashima, H Marotte, and P Miossec

Ann Rheum Dis 2005; 64: 509-510. doi:10.1136/ard.2004.021378

[Extract] [Full Text] [PDF] [Request Permissions]

Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren’s syndrome

Y Naito, I Matsumoto, E Wakamatsu, D Goto, T Sugiyama, R Matsumura, S Ito, A Tsutsumi, and T Sumida

Ann Rheum Dis 2005; 64: 510-511. doi:10.1136/ard.2004.025478

[Extract] [Full Text] [PDF] [Request Permissions]

Matters arising:

Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails? • Authors’ reply

M D Smith, P Durez, T A Nzeusseu, B R Lauwerys, D H Manicourt, J-P Devogelaer, F A Houssiau, P Verschueren, and R Westhovens

Ann Rheum Dis 2005; 64: 512.

[Extract] [Full Text] [PDF] [Request Permissions]

Antimicrobial treatment for Chlamydia induced reactive arthritis • Authors’ reply

J D Carter, J Valeriano, F B Vasey, J S H Gaston, and T K Kvien

Ann Rheum Dis 2005; 64: 512-513.

[Extract] [Full Text] [PDF] [Request Permissions]

Is Behçet’s syndrome associated with infection? • Authors’ reply

A P Rozin, G Hatemi, and H Yazici

Ann Rheum Dis 2005; 64: 513-515.

[Extract] [Full Text] [PDF] [Request Permissions]

Different threshold for prolactin response to hypoglycaemia in patients with rheumatoid arthritis? • Authors’ reply

R Imrich, M Vigas, J Rovensky, A M M Eijsbouts on behalf of the other authors

Ann Rheum Dis 2005; 64: 515-516.

[Extract] [Full Text] [PDF] [Request Permissions]

A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable? • Authors’ reply

M K Reinders, E N van Roon, J R B J Brouwers, T L Th A Jansen, A-K Tausche, and H E Schröder

Ann Rheum Dis 2005; 64: 516.

[Extract] [Full Text] [PDF] [Request Permissions]

Corrections:

CORRECTION

Ann Rheum Dis 2005; 64: 516. doi:10.1136/ard.2003.017087corr1

[Extract] [Full Text] [PDF] [Request Permissions]